AdvanSix Inc.

AdvanSix Inc.(ASIX)股票分析

$16.370

-0.129 (-0.79%)收盤時

Loading chart…
最高
16.720
開盤
16.550
成交量加權均價
16.43
成交量
162.70K
市值
606.64M
最低
16.200
成交金額
2.67M
企業價值/稅息折舊攤銷前利潤(TTM)
7.15

AdvanSix Inc. is a vertically integrated chemistry company that produces essential materials for diverse end markets across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin, under the Aegis brand name. It also markets and sells Caprolactam to manufacture polymer resins to produce fibers, compounds and other nylon products. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It manufactures sulfuric acid, ammonia and carbon dioxide. Its other intermediate chemicals include phenol, alpha-methyl styrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Its end-products for intermediates include automotive components and water treatment and pharmaceutical intermediates.

AI 分析 of AdvanSix Inc. (ASIX)

持有

AdvanSix Inc (ASIX) is currently not a strong buy. The stock is priced at $16.37, with a recent RSI of 47.68 indicating a neutral momentum. The forward P/E ratio is 0, suggesting uncertainty in future earnings, while the gross margin has decreased to 7.38% in Q2 2026, down from 14.32% in Q2 2025. The recent performance shows a year-to-date decline of 4.94% and a one-year change of -14.43%, indicating a lack of upward momentum. The main risk is the negative net income reported in Q1 2026 at -$15.5 million, which raises concerns about profitability moving forward.

分析師評級(2)

上檔空間 +16.07%
買進
2 買進
0 持有
0 賣出
目前: 16.37
最低
19.00
平均
19.00
最高
19.00

Truist

2026-02-23

目標價

$20

持有

Piper Sandler

2025-05-19

目標價

$32

增持

Piper Sandler

2025-05-18

目標價

$32

增持

Piper Sandler

2025-04-07

目標價

$26

持有

Piper Sandler

2025-03-18

目標價

$35

買進

估值指標

AdvanSix Inc.(ASIX)目前預期本益比為 0.00,5 年平均預期本益比為 10.75。

預期本益比

低估
5 年均值 P/E
10.75
目前P/E
0.00
高估
19.07
低估
2.43

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-76.52
目前EV/EBITDA
7.15
高估
275.41
低估
-428.45

預期股價營收比

低估
5 年均值 P/S
0.50
目前P/S
0.25
高估
0.65
低估
0.35

Alphio AI 對 ASIX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ASIX

$31.03

情境價格

基

基準

基準 · 50%ASIX

$29.59

情境價格

悲

悲觀

悲觀 · 25%ASIX

$28.13

情境價格

持有 ASIX 的大戶

C

Castleknight Management LP

+ 持有ASIX

-0.33%

3個月報酬率

事件時間軸

2026-08-07 (ET)

07:00:00

AdvanSix Reports Q2 Revenue of $421.28M

2026-05-08 (ET)

06:40:00

AdvanSix Reports Q1 Revenue of $404.18M

2026-05-07 (ET)

06:00:00

AdvanSix Enters Agreement to Expand Ammonia Platform in Hopewell

2026-04-13 (ET)

07:00:00

AdvanSix Appoints Patrick Day as CFO

2026-02-20 (ET)

07:00:00

AdvanSix Reports Q4 Revenue of $359.95M

資訊

ASIX 常見問題 —— 由 Alphio AI 解答

AdvanSix Inc. is a vertically integrated chemistry company that produces essential materials for diverse end markets across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin, under the Aegis brand name. It also markets and sells Caprolactam to manufacture polymer resins to produce fibers, compounds and other nylon products. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It manufactures sulfuric acid, ammonia and carbon dioxide. Its other intermediate chemicals include phenol, alpha-methyl styrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Its end-products for intermediates include automotive components and water treatment and pharmaceutical intermediates. It operates in the Basic Materials sector (PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTO industry).

AdvanSix Inc (ASIX) is currently not a strong buy. The stock is priced at $16.37, with a recent RSI of 47.68 indicating a neutral momentum. The forward P/E ratio is 0, suggesting uncertainty in future earnings, while the gross margin has decreased to 7.38% in Q2 2026, down from 14.32% in Q2 2025. The recent performance shows a year-to-date decline of 4.94% and a one-year change of -14.43%, indicating a lack of upward momentum. The main risk is the negative net income reported in Q1 2026 at -$15.5 million, which raises concerns about profitability moving forward.

2 analysts cover ASIX: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 19.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易